We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29.5M +$9.92K +245 +0%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$20.4M +$1.94M +47,938 +8%
BlackRock
3
BlackRock
New York
$13.8M -$492K -12,140 -3%
ABG
4
Ally Bridge Group
New York
$11.5M +$405K +10,000 +3%
AG
5
Artal Group
Luxembourg
$9.78M +$4.05M +100,000 +50%
FP
6
Flagship Pioneering
Massachusetts
$9.58M
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.1M -$792K -19,561 -7%
OFM
8
Omega Fund Management
Massachusetts
$8.19M
SB
9
Samsara BioCapital
California
$6.24M
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$6.19M +$405K +10,000 +6%
O
11
OrbiMed
New York
$5.99M
ACM
12
Altium Capital Management
New York
$3.78M -$455K -11,241 -9%
State Street
13
State Street
Massachusetts
$3.75M +$135K +3,337 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.11M +$387K +9,555 +11%
SCM
15
Sio Capital Management
New York
$2.94M
RCM
16
RA Capital Management
Massachusetts
$2.93M
CS
17
Candriam SCA
Luxembourg
$1.91M
Northern Trust
18
Northern Trust
Illinois
$1.71M +$810 +20 +0%
LCP
19
LGT Capital Partners
Switzerland
$1.63M +$1.85M +45,661 +1,052%
Goldman Sachs
20
Goldman Sachs
New York
$1.61M +$17.8K +439 +0.9%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.03M +$445K +10,990 +54%
Los Angeles Capital Management
22
Los Angeles Capital Management
California
$840K -$5.06K -125 -0.5%
GCP
23
GSA Capital Partners
United Kingdom
$789K +$534K +13,179 +119%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$633K -$8.5K -210 -1%
Nuveen
25
Nuveen
North Carolina
$611K -$72.8K -1,799 -9%